Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays

Frederika A van Nimwegen1, David J Cutter2, Michael Schaapveld1

  • 1Department of Psychosocial Research, Epidemiology, and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Insights

A new method uses radiation therapy simulation X-rays to estimate mean heart dose in Hodgkin lymphoma survivors, offering a faster, reproducible alternative to CT-based dosimetry for assessing cardiac complication risks.

Area of Science:

  • Radiation oncology
  • Cardiovascular health
  • Medical imaging

Background:

  • Mean heart dose is crucial for predicting late cardiovascular complications in Hodgkin lymphoma (HL) survivors.
  • Retrospective dose estimation for patients treated before CT planning is often labor-intensive.

Purpose of the Study:

  • To introduce and validate a novel method for estimating mean heart dose using simulation X-rays.
  • To provide a simpler, more efficient approach for retrospective dosimetry in HL patients.

Main Methods:

  • Cardiac contours were delineated on simulation X-rays from 42 HL survivors.
  • Mean heart dose was calculated using a formula involving cardiac contour percentage within the radiation field and prescribed mediastinal dose.
  • Results were compared to previously established CT-based dosimetry.

Main Results:

  • The simulation X-ray method demonstrated excellent inter-rater agreement (ICC=0.93).
  • Mean heart dose estimates were comparable between the simulation X-ray method (30.4 Gy) and CT-based dosimetry (30.2 Gy).
  • Good agreement (ICC=0.87) was found between the two dosimetry methods.

Conclusions:

  • Estimating mean heart dose from simulation X-rays is a reproducible and fast method.
  • This technique accounts for individual patient anatomy.
  • The simulation X-ray method provides results comparable to labor-intensive CT-based dosimetry, aiding studies on cardiac complications.
Abstract